<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-12-08">8 December 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Claudia</forename><surname>Vollbrecht</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Robert</forename><surname>Werner</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Essen</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">University of Duisburg-Essen</orgName>
								<address>
									<settlement>Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Robert</forename><forename type="middle">Fred</forename><surname>Henry</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Essen</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">University of Duisburg-Essen</orgName>
								<address>
									<settlement>Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">West German Lung Centre</orgName>
								<orgName type="institution">University Hospital Essen</orgName>
								<address>
									<settlement>Ruhrlandklinik</settlement>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">University of Duisburg-Essen</orgName>
								<address>
									<settlement>Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daniel</forename><forename type="middle">Christian</forename><surname>Christoph</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Oncology</orgName>
								<orgName type="institution" key="instit1">University Hospital Essen</orgName>
								<orgName type="institution" key="instit2">University of Duisburg-Essen</orgName>
								<address>
									<settlement>Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lukas</forename><forename type="middle">Carl</forename><surname>Heukamp</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Peifer</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Department of Translational Genomics</orgName>
								<orgName type="department" key="dep2">Cologne Center of Genomics</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Burkhard</forename><surname>Hirsch</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charite ´Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Molecular Diagnostics</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lina</forename><surname>Burbat</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charite ´Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Molecular Diagnostics</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Mairinger</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Helios Klinikum Emil von Behring</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kurt</forename><forename type="middle">Werner</forename><surname>Schmid</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Essen</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">University of Duisburg-Essen</orgName>
								<address>
									<settlement>Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jeremias</forename><surname>Wohlschlaeger</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Essen</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">University of Duisburg-Essen</orgName>
								<address>
									<settlement>Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Fabian</forename><surname>Dominik Mairinger</surname></persName>
							<email>fabian-dominik.mairinger@charite.de</email>
							<affiliation key="aff1">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Essen</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">University of Duisburg-Essen</orgName>
								<address>
									<settlement>Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">F</forename><forename type="middle">D</forename><surname>Mairinger</surname></persName>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department">Institute of Pathology</orgName>
								<address>
									<addrLine>Molecular Diagnostics, Hindenburgdamm 30</addrLine>
									<postCode>D-12200</postCode>
									<settlement>Charite ´Universita ¨tsmedizin Berlin, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="institution">Institute for Hematopathology Hamburg</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-12-08">8 December 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">8D1FF6E62DB75BC2F3666C029021B79A</idno>
					<idno type="DOI">10.1038/bjc.2015.397</idno>
					<note type="submission">Received 6 August 2015; revised 14 October 2015; accepted 15 October 2015;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:19+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>carcinoids</term>
					<term>SCLC</term>
					<term>NGS</term>
					<term>targeted sequencing</term>
					<term>massive parallel sequencing</term>
					<term>lung cancer</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Lung cancer is the leading cause of cancer-related deaths worldwide.</s><s>The typical and atypical carcinoid (TC and AC), the large-cell neuroendocrine carcinoma (LCNEC) and the small-cell lung cancers (SCLC) are subgroups of pulmonary tumours that show neuroendocrine differentiations.</s><s>With the rising impact of molecular pathology in routine diagnostics the interest for reliable biomarkers, which can help to differentiate these subgroups and may enable a more personalised treatment of patients, grows.</s></p><p><s>Methods: A collective of 70 formalin-fixed, paraffin-embedded (FFPE) pulmonary neuroendocrine tumours (17 TCs, 17 ACs, 19 LCNECs and 17 SCLCs) was used to identify biomarkers by high-throughput sequencing.</s><s>Using the Illumina TruSeq Amplicon-Cancer Panel on the MiSeq instrument, the samples were screened for alterations in 221 mutation hot spots of 48 tumour-relevant genes.</s></p><p><s>Results: After filtering 426 000 detected variants by applying strict algorithms, a total of 130 mutations were found in 29 genes and 49 patients.</s></p><p><s>Mutations in JAK3, NRAS, RB1 and VHL1 were exclusively found in SCLCs, whereas the FGFR2 mutation was detected in LCNEC only.</s><s>KIT, PTEN, HNF1A and SMO were altered in ACs.</s><s>The SMAD4 mutation corresponded to the TC subtype.</s><s>We prove that the frequency of mutations increased with the malignancy of tumour type.</s><s>Interestingly, four out of five ATM-mutated patients showed an additional alteration in TP53, which was by far the most frequently altered gene (28 out of 130; 22%).</s><s>We found correlations between tumour type and IASLC grade for ATM-(P ¼ 0.022; P ¼ 0.008) and TP53-mutated patients (Po0.001).</s><s>Both mutated genes were also associated with lymph node invasion and distant metastasis (Pp0.005).</s><s>Furthermore, PIK3CA-mutated patients with high-grade tumours showed a reduced overall survival (P ¼ 0.040) and the mutation frequency of APC and ATM in high-grade neuroendocrine lung cancer patients was associated with progression-free survival (PFS) (P ¼ 0.020).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions:</head><p><s>The implementation of high-throughput sequencing for the analysis of the neuroendocrine lung tumours has revealed that, even if these tumours encompass several subtypes with varying clinical aggressiveness, they share a number of molecular features.</s><s>An improved understanding of the biology of neuroendocrine tumours will offer the opportunity for novel approaches in clinical management, resulting in a better prognosis and prediction of therapeutic response.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Lung cancer is the leading cause of cancer-related deaths worldwide, with 15% of cases showing only a 5-year survival rate.</s><s>Nearly one-fourth of all lung neoplasms originate from cells of the diffuse neuroendocrine system and are classified as neuroendocrine tumours (NET) <ref type="bibr" target="#b29">(Rekhtman, 2010)</ref>.</s><s>This spectrum of neoplasms is composed of the high-grade small-cell lung cancer (SCLC), the large-cell neuroendocrine carcinoma (LCNEC), as well as the lowgrade typical (TC) and atypical carcinoids (AC) <ref type="bibr" target="#b40">(Takei et al, 2002)</ref>.</s></p><p><s>Although smoking is not correlating with carcinoids, most of LCNEC and all SCLC patients exhibit a smoking history <ref type="bibr" target="#b42">(Travis, 2009;</ref><ref type="bibr" target="#b39">Swarts et al, 2012)</ref>.</s><s>Even though tumours are detected at an early stage, SCLCs and LCNECs show the poorest clinical outcome as compared with other lung tumours because of their high malignancy <ref type="bibr" target="#b40">(Takei et al, 2002)</ref>.</s><s>The 5-year survival rate of patients with SCLC is o5% <ref type="bibr" target="#b29">(Rekhtman, 2010)</ref>.</s><s>The same holds true for LCNECs that show a similar progression with 5-year survival rates varying from 15% up to 57%, depending on the source of information <ref type="bibr" target="#b1">(Asamura et al, 2006;</ref><ref type="bibr" target="#b29">Rekhtman, 2010)</ref>.</s><s>In contrast, patients suffering from TC show excellent survival rates of up to 100%.</s><s>Nevertheless, some of them present with lymph node metastasis (4-15%) <ref type="bibr" target="#b43">(Travis et al, 1998;</ref><ref type="bibr" target="#b2">Beasley et al, 2000;</ref><ref type="bibr" target="#b13">Fink et al, 2001;</ref><ref type="bibr" target="#b41">Thomas et al, 2001;</ref><ref type="bibr" target="#b5">Cardillo et al, 2004;</ref><ref type="bibr" target="#b24">Pelosi et al, 2005;</ref><ref type="bibr" target="#b1">Asamura et al, 2006;</ref><ref type="bibr" target="#b15">Garcia-Yuste et al, 2007;</ref><ref type="bibr" target="#b28">Rea et al, 2007;</ref><ref type="bibr" target="#b42">Travis, 2009)</ref>.</s><s>Atypical carcinoids are more aggressive and show a higher frequency of nodal metastasis (35-64%) with decreased survival rates ranging from 61% to 88% <ref type="bibr" target="#b2">(Beasley et al, 2000;</ref><ref type="bibr" target="#b13">Fink et al, 2001;</ref><ref type="bibr" target="#b35">Scott, 2003;</ref><ref type="bibr" target="#b5">Cardillo et al, 2004;</ref><ref type="bibr" target="#b24">Pelosi et al, 2005;</ref><ref type="bibr" target="#b1">Asamura et al, 2006;</ref><ref type="bibr" target="#b15">Garcia-Yuste et al, 2007;</ref><ref type="bibr" target="#b28">Rea et al, 2007)</ref>.</s></p><p><s>During lung carcinogenesis, cells stepwise accumulate multiple genetic and epigenetic abnormalities that lead to immortalisation, uncontrolled proliferation and spread of these altered cells <ref type="bibr" target="#b3">(Brambilla et al, 2003)</ref>.</s><s>This is often initiated by the presence of mutations, but can also be an effect of chromosomal aberrations <ref type="bibr" target="#b11">(Esteller et al, 1999;</ref><ref type="bibr" target="#b47">Zochbauer-Muller et al, 2001)</ref>.</s><s>In particular, the most common mutated gene in lung cancer is the tumour suppressor TP53, encoding a protein that induces cell growth arrest and apoptosis and mediates cell cycle regulation.</s><s>In contrast to pulmonary carcinoids, which are rarely TP53 altered, up to 50% of non-small-cell lung cancer (NSCLC) and 470% of SCLCs were associated with mutations in this gene <ref type="bibr" target="#b44">(Travis et al, 2004)</ref>.</s><s>In addition, the crucial retinoblastoma (RB) pathway is often inactivated.</s><s>Up to 100% of high-grade NETs like SCLCs or LCNECs are affected by the loss of the RB protein <ref type="bibr" target="#b44">(Travis et al, 2004)</ref>.</s></p><p><s>The advent of next-generation sequencing (NGS) systems allows a very sensitive analysis of multiple patients and targets simultaneously.</s><s>Therefore, further mutational analysis of neuroendocrine lung tumours by a high-throughput sequencing approach helps to gain more insight into their genetic profile, enabling a further subdivision of these different groups.</s><s>Here we subjected, for the first time, 70 neuroendocrine lung tumours to a targeted NGS approach based on sequencing-by-synthesis chemistry, feasible for formalin-fixed, paraffin embedded (FFPE) material.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head><p><s>Demographic data and study design.</s><s>The study is based on a collective of 70 representative, FFPE neuroendocrine lung tumours <ref type="bibr">(17 TCs,</ref><ref type="bibr">17 ACs,</ref><ref type="bibr">19</ref> LCNECs and 17 SCLCs) used for massive parallel sequencing purposes.</s><s>The initial diagnosis was re-evaluated by two experienced pathologists (JW and TM).</s><s>Inclusion criteria were sufficient tumour material (tumour cell count 50-80%) and a minimum of contamination by lymphocytic and stromal cells.</s><s>All analysed cases comprise surgical resection.</s><s>The surgical resected SCLCs were resected as initial unknown tumoural lesion and were afterwards diagnosed as SCLC.</s><s>All investigated SCLCs were classified as limited or very limited diseases (VLDL).</s><s>Specimens were collected at the Institute of Pathology at the University Hospital Essen (Essen, Germany) from 2005 till 2012.</s><s>The TNM staging was based on the WHO Classification Of Tumours guidelines (2004) <ref type="bibr" target="#b44">(Travis et al, 2004)</ref>).</s><s>The mean age at date of diagnosis was 58.6 years (median age: 59.0 years; 95% CI: 50.8-66.9</s><s>months).</s><s>Survival data were available for 34 patients with 12 reported deaths at the time of data collection.</s><s>Survival data were collected for the highgrade group as well as overall survival (OS) for 3 carcinoid tumours showing an aggressive course with reported death after 4.4, 7.3 and 11.3 months, respectively.</s><s>For the remaining carcinoids, no survival data were collected because of their excellent prognosis.</s></p><p><s>The study was conducted retrospectively for the identification of biomarkers.</s><s>Patients who received chemotherapy before resection of tumour tissue specimens were excluded.</s><s>The study was approved by the ethical committee of the University Hospital Essen (ID: 13-5382-BO).</s><s>The investigations conform to the principles outlined in the declaration of Helsinki.</s><s>Patient characteristics are summarised in Table <ref type="table" target="#tab_0">1</ref>.</s></p><p><s>DNA extraction.</s><s>For DNA isolation, FFPE tissue slides of 4 mm were prepared using a microtome Cool Cut HM 355S (MICROM International, Walldorf, Germany).</s><s>Three to five paraffin tissue slides per sample were deparaffinised with xylene before DNA extraction.</s><s>Genomic DNA was isolated via Maxwell 16 Research (Promega, Madison, WI, USA) as recommended by the manufacturer.</s><s>Following, DNA quantification was performed using Nanodrop ND-1000 (Thermo Fisher Scientific, Waltham, MA, USA) and Qubit (Life Technologies, Carlsbad, CA, USA).</s></p><p><s>Targeted next-generation sequencing.</s><s>Sample preparation was done using the TruSeq Amplicon-Cancer Panel (Illumina, San Diego, CA, USA).</s><s>Therefore, 424 target-specific probes, covering 221 mutation hot spots of 48 tumour-relevant genes, were used to capture the regions of interest (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Furthermore, each sample was labelled with a barcode sequence consisting of eight individual nucleotides, in a final PCR step.</s><s>A total of 212 amplicons per sample with a mean length of 180 base pairs were sequenced paired-end on the MiSeq instrument (Illumina) using the v1 chemistry.</s><s>Sample preparation and sequencing procedure was performed according to the standard protocols provided by the manufacturer.</s></p><p><s>Sequencing data analysis.</s><s>Fastq files generated by the MiSeq reporter software (Illumina) were used for further analysis with a customised bioinformatics pipeline based on the general cancer genome analysis algorithm published by <ref type="bibr" target="#b23">Peifer et al (2012)</ref>.</s><s>Subsequently, data filtering was done by excluding variants with o25 effective reads (total reads Â (percent variant reads/100)) and by excluding variants with o5% allele frequency.</s><s>Afterwards, synonymous alterations were removed and visual analysis of called variants was performed by means of the Integrative Genomic Viewer (IGV, Broad Institute, Cambridge, MA, USA).</s><s>False positive variants, particularly in repetitive or highly homologous regions of the genome, variants in high background noise, as well as singlestrand variants, were eliminated when they were clearly recognisable as artefacts.</s><s>Finally, obtained variants were analysed for their functional impact on the protein by MutationAssessor (http:// mutationassessor.org,</s><s>release 2) <ref type="bibr" target="#b30">(Reva et al, 2011)</ref> and Variant Effect Predictor (VEP, Ensembl release 78) <ref type="bibr" target="#b22">(McLaren et al, 2010)</ref> implementing the bioinformatics tools SIFT (sorting intolerant from tolerant) <ref type="bibr" target="#b19">(Kumar et al, 2009)</ref> and PolyPhen2 (polymorphism phenotyping v2) <ref type="bibr" target="#b0">(Adzhubei et al, 2010)</ref>.</s><s>Only mutations with a functional impact as determined by at least two of the three applied algorithms as well as frameshift deletions/insertion and alterations leading to a stop codon were used for statistical analysis.</s></p><p><s>Statistical analysis.</s><s>All statistical analyses were performed using the R environment for statistical computing and graphics (R Foundation, Vienna, Austria).</s><s>For dichotomous factors and linear vectors the Wilcoxon Mann-Whitney rank sum test was applied.</s><s>For variance analysis of variables with more than two categories, the Kruskal-Wallis test was performed.</s><s>Double dichotomous contingency tables (e.g., mutational status to lymph node invasion status) were analysed using Fisher's exact test.</s><s>To test dependence of ranked parameters with more than two groups (e.g., mutational status and tumour type) Pearson's w 2 test was used.</s><s>Kaplan-Meier analysis was performed to test associations between mutation status and OS as well as progression-free survival (PFS).</s><s>The PFS was calculated from the first day of chemotherapy until radiologic progression, death from any cause or the last time of follow-up without progression.</s><s>Overall survival was defined as the time from date of diagnosis until the date of death or last follow-up.</s><s>Patients were censored at the last follow-up if still alive or loss of follow-up.</s><s>Surveillance of PFS and OS was stopped on 31 August 2014.</s><s>Significant differences in PFS or OS between groups were verified by the Wald test, likelihood ratio test and Score (logrank) test (Supplementary Table <ref type="table" target="#tab_2">S3</ref>).</s><s>The level of statistical significance was defined as Pp0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>Run parameters and sequencing quality.</s><s>A total of 70 neuroendocrine lung cancers were sequenced with 4 MiSeq runs, containing 23 or 24 samples per run.</s><s>Samples showing coverages with o250 median read counts per amplicon (23 out of 70) were resequenced with an additional fifth run.</s></p><p><s>Bridge amplification of the target regions on the flow cell resulted in an average cluster density of 641 K mm À 2 with B80% of the generated clusters passing the quality filter parameters.</s><s>In total, the sequencing runs produced an average of 3.65 Â 10 6 reads and an average output of 1.1 gigabases.</s><s>The runs showed read quality parameters with average Q30 scores (equals a 0.1% chance of a wrong base call at this position) of B63% in a range of 8-85% (Supplementary Table <ref type="table" target="#tab_0">S1</ref>).</s><s>Approximately 60% of the targets showed coverages between 500 and 2000 reads (Supplementary Figure <ref type="figure" target="#fig_0">S1</ref>).</s></p><p><s>Variant filtering and mutation detection.</s><s>The sequencing analysis of all five runs revealed a total of 26 945 variants.</s><s>Removal of variants with o25% effective reads and variants with o5% allele frequency resulted in 643 variants.</s><s>Finally, additional removal of variants clearly recognised as artefacts resulted in 254 variants that were further analysed according to their functional relevance, leading to a total of 130 mutations in 29 genes (Table <ref type="table" target="#tab_2">3</ref>) detected in 49 of 70 FFPE neuroendocrine lung tumour samples (Figure <ref type="figure" target="#fig_0">1</ref> and Supplementary Table <ref type="table" target="#tab_1">S2</ref>).</s><s>No variants were found in the remaining 19 genes.</s></p><p><s>The mutation status of some genes was associated with a special subtype of the pulmonary NETs (Table <ref type="table" target="#tab_2">3</ref> and Figure <ref type="figure" target="#fig_1">2A</ref>).</s><s>Mutations in JAK3 (exon 16: p.W690*), NRAS (exon 2: p.G13D, p.S17N), RB1 (exon 18: p.P595L; exon 20: H673Y) and VHL1 (exon 3: Q164*) were exclusively found in SCLCs, whereas the detected FGFR2 mutation p.A264T in exon 7 was only associated with LCNEC.</s><s>The KIT (exon 10: p.K546delinsGG; exon 13 p.M638fs), PTEN (exon 8: p.P339S), HNF1A (exon 4: p.G288fs) and SMO (exon 5: p.L367R) alterations were only found in ACs and the SMAD4 (exon 5: p.Q169*, exon 5) mutation corresponded to the TC subtype.</s></p><p><s>Furthermore, the total mutation frequency increased with the malignancy of the tumour type.</s><s>Of the 130 mutations, 11 (9%) were related to TCs (mean: 0.6 per sample), 21 (16%) were found in ACs (mean: 1.2 mutations per sample) and 38 (29%) were related to LCNECs (mean: 1.9 per sample).</s><s>Patients associated to SCLC showed the highest mutation frequency of 46% with 60 detected mutations (mean: 3.5 per sample).</s><s>This effect was especially observed for ATM, ERBB2, ERBB4, PIK3CA, RET and TP53 (Figure <ref type="figure" target="#fig_1">2B</ref>).</s><s>Interestingly, four of five ATM mutated patients also showed an alteration in the tumour suppressor TP53, and this was by far the most frequently altered gene (31 out of 130; 24%) followed by ERBB2 (11 out of 130, 9%), PIK3CA with 8 (6%) and EGFR present with 7 mutations (5%).</s><s>We found significant correlations between tumour type and IASLC grade for ATM (P ¼ 0.022; P ¼ 0.008) and TP53 mutated patients (P40.001;</s><s>Po0.001).</s><s>In addition, TP53 showed significant more multiple mutations (Po0.001).</s><s>Both genes were also associated with lymph node invasion and distant metastasis when they were mutated (both Pp0.005).</s></p><p><s>Moreover, the frequency of variants in ATM and APC in highgrade neuroendocrine lung cancer patients was associated with PFS (P ¼ 0.020; Figure <ref type="figure" target="#fig_2">3A</ref>).</s><s>Finally, PIK3CA mutated patients with high-grade tumours showed a reduced OS compared with their wild-type counterparts (P ¼ 0.040; Figure <ref type="figure" target="#fig_2">3B</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>In contrast to NETs of other organ systems (e.g., gastrointestinal), pulmonary NETs form two prognostically different groups: the low-grade carcinoid tumours (TC and AC) and the high-grade carcinomas (LCNEC and SCLC) <ref type="bibr" target="#b32">(Rindi et al, 2014)</ref>.</s><s>The detailed molecular characteristic of these subgroups still remains unknown.</s></p><p><s>Here, for the first time, we describe a targeted high-throughput parallel sequencing approach used to analyse 70 neuroendocrine lung tumours for alterations in 221 hot spots of 48 genes suspected to play an important role in the tumourigenesis.</s><s>Entity-specific mutations identified by this method can potentially serve as markers for classification of neuroendocrine lung tumours in diagnostics or therapy decision.</s></p><p><s>Our data confirm previous findings <ref type="bibr" target="#b21">(Lohmann et al, 1993;</ref><ref type="bibr" target="#b27">Przygodzki et al, 1996;</ref><ref type="bibr" target="#b7">Couce et al, 1999;</ref><ref type="bibr" target="#b20">Leotlela et al, 2003;</ref><ref type="bibr" target="#b39">Swarts et al, 2012)</ref>, showing that mutations in the TP53 gene increase with malignancy of the tumour subtype.</s><s>The TP53 alterations detected in this study ranged from none in carcinoid tumours to 11 in the 17 analysed SCLC samples.</s><s>Interestingly, the same trend was observed for ATM mutations.</s><s>Furthermore, four out of five ATM mutated patients showed co-alterations in TP53 (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>ATM is a serine/ threonine kinase that coordinates an integrated cellular response to DNA damage by double-stranded DNA breaks and acts upstream of TP53 where it leads to the activation of an apoptotic pathway <ref type="bibr" target="#b26">(Pettitt et al, 2001)</ref>.</s><s>Furthermore, it activates several TP53-independent cellular pathways and it is conceivable that mutations in both genes could increase the survival advantage of a malignant tumour cell clone.</s><s>Subsequently, additional mutations in APC, which is a downstream target of TP53, could possibly enhance the survival benefit for certain tumour subclones.</s><s>Actually, two out of seven APC mutations detected in our study were observed coincidentally with an ATM or with ATM and TP53 mutations, pointing out a second or third hit mechanism during tumourigenesis.</s></p><p><s>Interestingly, the group of R Thomas (Fernandez-Cuesta et al, 2014) identified mutations in genes related to chromatin remodelling (including MEN1, ARID1A and EIF1AX) as frequent events in pulmonary carcinoids.</s><s>In addition, mutations in the histone methyltransferases (including SETD1B, SETDB1 and NSD1) as well as demethylases (KDM4A, PHF8, JMJD1C and others) were determined <ref type="bibr" target="#b12">(Fernandez-Cuesta et al, 2014)</ref>.</s><s>Likewise, his working group proofed the appearance of CREBBP and EP300 histone acetyltransferases as well as the histone-modifying enzyme MLL in high-grade lung cancers in another study <ref type="bibr" target="#b23">(Peifer et al, 2012)</ref>, indicating that histone modifications play a crucial role in neuroendocrine lung cancer tumourigenesis and progression.</s></p><p><s>Activating mutations in the EGFR gene have been widely studied in NSCLC <ref type="bibr" target="#b10">(Engle and Kolesar, 2014;</ref><ref type="bibr" target="#b17">Karachaliou and Rosell, 2014;</ref><ref type="bibr" target="#b31">Revannasiddaiah et al, 2014)</ref>.</s><s>Unfortunately, although new therapeutic strategies are urgently needed for metastatic pulmonary carcinoid tumours, this subgroup of lung neoplasia is totally neglected, so far.</s><s>Instead of common activating EGFR mutations, we found alterations located in the TOPO domain in all four tumour subtypes.</s><s>In particular, the p.A859V in exon 21 may activate the EGF receptor similarly to the well-known therapeutically relevant activating p.L858R mutation <ref type="bibr" target="#b25">(Peng et al, 2014)</ref>.</s><s>Of note, in one patient we observed that EGFR mutations were located in different regions of the gene.</s><s>Importantly, these complex events are also under suspicion to predict a response to tyrosine kinase inhibitor (TKI) therapy <ref type="bibr" target="#b25">(Peng et al, 2014)</ref>.</s></p><p><s>Similar to EGFR, both other investigated members of the ERBB superfamily (ERBB2 and ERBB4) also showed mutations in the extracellular TOPO domain (11 samples; 2 TCs and ACs, 3 LCNECs and 4 SCLCs).</s><s>In addition, the growth factor receptor PDGFRA is impaired in four samples (one TC, one LCNEC and two SCLCs).</s><s>Furthermore, KDR (VEGFR2) is mutated in one AC and two LCNECs.</s><s>Of note, KDR p.Q427H variant in exon 11, located in the protein kinase domain, occurred in approximately one-third of all carcinoids and the half of all investigated carcinomas.</s><s>Although all three applied algorithms predicted a benign or tolerated alteration of  Abbreviations: AC ¼ atypical carcinoid; LCNEC ¼ large-cell neuroendocrine carcinoma; SCLC ¼ small-cell lung cancer; TC ¼ typical carcinoid.</s><s>JAK3, NRAS, RB1 as well as VHL variants were exclusively found in SCLCs, whereas the FGFR2 mutation was only detected in LCNEC.</s><s>The KIT, PTEN and SMO alterations were determined in ACs and the SMAD4 variant in TC subtype only.</s></p><formula xml:id="formula_0">JAK3 (n ¼ 1) 0 0 0 100 NRAS (n ¼ 2) 0 0 0 100 RB1 (n ¼ 2) 0 0 0 100 VHL (n ¼ 1) 0 0 0 100 ATM (n ¼ 7) 0 0 14<label>86</label></formula><formula xml:id="formula_1">TP53 (n ¼ 31) 0 0 48 52 ALK (n ¼ 2) 0 0 50 50 BRAF (n ¼ 3) 0 0 67<label>33</label></formula><formula xml:id="formula_2">FGFR2 (n ¼ 1) 0 0 100 0 PIK3CA (n ¼ 8) 0 13 13<label>75</label></formula><formula xml:id="formula_3">ERBB4 (n ¼ 5) 0 20 40<label>40</label></formula><formula xml:id="formula_4">KDR (n ¼ 3) 0 33 67 0 KRAS (n ¼ 3) 0 33 67 0 MET (n ¼ 3) 0 33 67 0 SMARCB1 (n ¼ 2) 0 50 0<label>50</label></formula><formula xml:id="formula_5">FGFR1 (n ¼ 2) 0 50 50 0 KIT (n ¼ 2) 0 100 0 0 PTEN (n ¼ 1) 0 100 0 0 SMO (n ¼ 1) 0 100 0 0 HNF1A (n ¼ 1) 0 100 0 0 RET (n ¼</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mutation frequency</head><p><s>Malignancy of tumour subtype  the protein, the KDR p.Q427H mutation is reported to be associated with an increased risk of coronary heart disease and has been detected in patients with NSCLC <ref type="bibr" target="#b45">(Wang et al, 2007;</ref><ref type="bibr" target="#b16">Glubb et al, 2011)</ref>.</s><s><ref type="bibr" target="#b16">Glubb et al (2011)</ref> demonstrated that this alteration can modestly increase VEGFR-2 signaling and may be also associated with increased lung tumour vascularisation.</s><s>The high proportion of neuroendocrine lung tumours showing this alteration underlines the hypothesis that it might be a potential marker for future risk assessment in a diagnostic setting.</s><s>Interestingly, downstream of these receptor tyrosine kinases, well-known activating mutations were observed in both NRAS and KRAS.</s><s>Pathway activation downstream of EGFR, for example, by KRAS mutations, is known to be a resistance mechanism for EGFR-TKI therapeutic approaches <ref type="bibr" target="#b9">(Engelman et al, 2006)</ref>.</s><s>Activation downstream of BRAF, primary by NRAS mutations, is reported to act as a potential resistance mechanism against vemurafenib therapy <ref type="bibr" target="#b37">(Sos et al, 2014)</ref>.</s><s>Even continued activation of PI3K signalling by a PIK3CA oncogenic mutant was shown to be sufficient to abrogate gefitinib-induced apoptosis <ref type="bibr" target="#b9">(Engelman et al, 2006)</ref>.</s><s>Additional studies confirmed mutations in the PI3K pathway to be involved in different EGFR resistance mechanisms <ref type="bibr" target="#b36">(Sequist et al, 2011)</ref>.</s><s>Such mutations were detected in our cohort of NETs including variants affecting the C2-PI3K domain as well as the PI3K-ABD domain and the PI3K/PI4K domain of the PIK3CA gene locus.</s><s>Our findings bear analogy to the previously published results of <ref type="bibr" target="#b4">Capodanno et al (2012)</ref> who also found PIK3CA mutations in neuroendocrine lung cancers correlated to an increase of entities' malignancy.</s><s>In contrast to our present study, the frequency of mutations detected by <ref type="bibr" target="#b4">Capodanno et al (2012)</ref> is as twice as high, mainly consisting of C:G4T:A transversions (481%).</s><s>Considering the use of FFPE material, this high mutation frequency has to be assessed critically.</s><s>To overcome this problem, we assessed a very stringent filtering mechanism for data analysis to avoid fixation artefacts.</s></p><formula xml:id="formula_6">TP53 1 1 1 1 1 3 1 1 1 1 1 2 1 1 3 1 3 2 1 1 1 1 1 ERBB2 1 1 1 1 1 1 1 1 1 1 1 RET 1 1 1 2 1 1 PIK3CA 1 1 2 1 1 2 EGFR 1 2 1 1 1 1 ATM 1 1 3 1 1 APC 1 1 1 1 1 2 IDH 2 1 2 ERBB4 1 2 2 ABL1 1 1 1 2 PDGFRA 1 1 1 1 MET 1 1 1 KRAS 1 1 1 KDR 1 2 BRAF 1 1 1 SMARCB1 1 1 RB1 1 1 NRAS 2 KIT 1 1 HNF1A 1 GNAS 1 1 FGFR1 1 1 ALK 1 1 VHL 1 SMO 1 SMAD4 1 PTEN 1 JAK3 1<label>FGFR2</label></formula><formula xml:id="formula_7">J A K 3 ( n = 1 ) R B 1 ( n = 2 ) V H L ( n = 1 ) A T M ( n = 7 ) T P 5 3 ( n = 3 1 ) A L K ( n = 2 ) B R A F ( n = 3 ) F G F R A 2 ( n = 1 ) P I K 3 C A ( n = 8 ) E R B B 4 ( n = 5 ) K D R ( n = 3 ) K R A S ( n = 3 ) M E T ( n = 3 ) S M A R C B 1 ( n = 2 ) F G F R 1 ( n = 2 ) K I T ( n = 2 ) P T E N ( n = 1 ) S M O ( n = 1 ) H N F 1 A ( n = 1 ) R E T ( n = 7 ) E G F R ( n = 7 ) A P C ( n = 7 ) E R B B 2 ( n =<label>1</label></formula><p><s>The RET proto-oncogene, a member of the cadherin superfamily, encodes a receptor tyrosine kinase.</s><s>Mutations in this gene are associated with the disorders multiple endocrine neoplasia (MEN) type IIA and IIB and medullary thyroid carcinoma <ref type="bibr" target="#b18">(Krampitz and Norton, 2014)</ref>.</s><s>In line with previous findings in other endocrine tumour entities <ref type="bibr" target="#b33">(Rotondi et al, 2009;</ref><ref type="bibr" target="#b34">Schulte et al, 2010;</ref><ref type="bibr" target="#b6">Colombo et al, 2015;</ref><ref type="bibr" target="#b46">Yeganeh et al, 2015)</ref>, we determined RET variants in B9% (6 out of 70) of pulmonary NET patients.</s><s>By the way, the activating p.M918T RET mutation was previously assessed in one metastatic SCLC specimen <ref type="bibr" target="#b8">(Dabir et al, 2014)</ref>.</s><s>In contrast, <ref type="bibr" target="#b14">Futami et al (2003)</ref> could not proof mutations but LOH of RET in the majority of SCLCs.</s><s>Nevertheless, the analysed collective was very small (8 informative samples) <ref type="bibr" target="#b14">(Futami et al, 2003)</ref>.</s><s>In carcinoid tumours, high gene expression of RET was associated with low long time survival but was not proven on protein level and also mutations in the RET oncogene could not be identified in any samples of the study <ref type="bibr" target="#b38">(Swarts et al, 2013)</ref>.</s><s>In our collective we found one RET mutation in each TC and AC.</s></p><p><s>Summing up, the implementation of targeted high-throughput sequencing for the analysis of the neuroendocrine lung tumours has revealed that these tumours, even if they vary in their clinical aggressiveness, share a number of molecular features.</s><s>The impact of these alterations for tumourigenesis and progression of the tumour has to be addressed in further studies, may be smoothing the way for enhanced therapeutic option in the near future.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Genetic profile of four analysed neuroendocrine lung tumour subtypes carrying gene mutations determined by targeted massive parallel sequencing are shown.</s><s>Columns represent mutations per patient; rows summarise mutations occurring in a particular gene.</s><s>Dark blue boxes indicate more than one mutation per patient in the corresponding gene.</s></p></div></figDesc><graphic coords="5,65.09,59.47,483.86,255.14" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2</head><label>2</label><figDesc><div><p><s>Figure 2. (A)Genes within entity-specific mutation frequency are shown.</s><s>The JAK3, NRAS, RB1 and VHL variants were just detected in SCLCs, whereas ATM, TP53, ALK and BRAF mutations were found in both high-grade tumour entities.</s><s>The FGFR2 mutation occurred exclusively in LCNEC.</s><s>The KIT, PTEN, HNF1A and SMO variants were only found in ACs, and the SMAD4 variant was only present in TC.</s><s>The GNAS mutations were limited to carcinoids.</s><s>(B) Specific genes showing a higher mutation frequency with increasing tumour malignancy.</s><s>The bars indicate the distribution of the mutation between the different tumour entities.</s><s>The TP53 and ATM variants were just detected in high-grade tumours with ATM variants mostly in SCLCs; PIK3CA and ERBB4 showed additional variants in AC; RET mutations were present in all four entities, but mainly in SCLCs, whereas ERBB2 showed an increasing mutation frequency with an increase of the tumour malignancy.</s></p></div></figDesc><graphic coords="5,142.61,547.03,338.78,114.50" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Kaplan-Meier curves for progression-free survival (PFS) (A) and overall survival (OS) (B) differentiated by the patients' mutational status are shown.</s><s>Because of the excellent survival rate of pulmonary carcinoids, only high-grade cases are depicted.</s><s>Of note, samples had mutations in both ATM and APC, showing an association to PFS (P ¼ 0.020).</s><s>The relation of this double mutation has to be clarified.</s><s>The PIK3CA mutated patients with high-grade tumours showed a reduced OS compared with their wild-type counterparts (P ¼ 0.040).</s></p></div></figDesc><graphic coords="6,151.97,56.71,140.90,140.90" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Patient characteristics</s></p></div></figDesc><table><row><cell>Absolute</cell></row></table><note><p><s>Median (range)4.6</s><s>(0.2-52.8)</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Genes included in the TruSeq Amplicon-Cancer Panel (Illumina)</s></p></div></figDesc><table><row><cell>ABL1</cell><cell>AKT1</cell><cell>ALK</cell><cell>APC</cell><cell>ATM</cell><cell>BRAF</cell><cell>CDH1</cell><cell>CDKN2A</cell></row><row><cell>CSF1R</cell><cell>CTNNB1</cell><cell>EGFR</cell><cell>ERBB2</cell><cell>ERBB4</cell><cell>FBXW7</cell><cell>FGFR1</cell><cell>FGFR2</cell></row><row><cell>FGFR3</cell><cell>FLT3</cell><cell>GNA11</cell><cell>GNAQ</cell><cell>GNAS</cell><cell>HNF1A</cell><cell>HRAS</cell><cell>IDH1</cell></row><row><cell>JAK2</cell><cell>JAK3</cell><cell>KDR</cell><cell>KIT</cell><cell>KRAS</cell><cell>MET</cell><cell>MLH1</cell><cell>MPL</cell></row><row><cell>NOTCH1</cell><cell>NPM1</cell><cell>NRAS</cell><cell>PDGFRA</cell><cell>PIK3CA</cell><cell>PTEN</cell><cell>PTPN11</cell><cell>RB1</cell></row><row><cell>RET</cell><cell>SMAD4</cell><cell>SMARCB1</cell><cell>SMO</cell><cell>SRC</cell><cell>STK11</cell><cell>TP53</cell><cell>VHL</cell></row></table><note><p><s>The panel consists of 2 Â 212 probes covering 221 mutation hot spots in 48 genes known to be important in human cancerogenesis.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Distribution of mutations between the different tumour subtypes</s></p></div></figDesc><table><row><cell>TC (%)</cell><cell>AC (%)</cell><cell>LCNEC (%) SCLC (%)</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.bjcancer.com | DOI:10.1038/bjc.2015.397</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AUTHOR CONTRIBUTIONS</head><p><s>All authors have read and approved the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICT OF INTEREST</head><p><s>The authors declare no conflict of interest.</s><s>This work is published under the standard license to publish agreement.</s><s>After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License.</s><s>Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)</s><s>Parallel sequencing of neuroendocrine lung cancers</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">A method and server for predicting damaging missense mutations</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Adzhubei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Peshkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">E</forename><surname>Ramensky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gerasimova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Kondrashov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Sunyaev</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Methods</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="248" to="249" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Neuroendocrine neoplasms of the lung: a prognostic spectrum</title>
		<author>
			<persName><forename type="first">H</forename><surname>Asamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kameya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Matsuno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Noguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ishikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yokose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">X</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nagai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="70" to="76" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Pulmonary atypical carcinoid: predictors of survival in 106 cases</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Beasley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Thunnissen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Brambilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hasleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Steele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Hammar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">V</forename><surname>Colby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sheppard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shimosato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Koss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Falk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Travis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1255" to="1265" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Early detection of lung cancer: role of biomarkers</title>
		<author>
			<persName><forename type="first">C</forename><surname>Brambilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fievet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jeanmart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>De Fraipont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lantuejoul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Frappat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ferretti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Y</forename><surname>Brichon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moro-Sibilot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J Suppl</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="36" to="44" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Phosphatidylinositol-3-kinase alpha catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours</title>
		<author>
			<persName><forename type="first">A</forename><surname>Capodanno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Boldrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pelliccioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mussi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fontanini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1559" to="1566" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Bronchial carcinoid tumors: nodal status and long-term survival after resection</title>
		<author>
			<persName><forename type="first">G</forename><surname>Cardillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Martino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Graziano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Giunti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Carbone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Facciolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Martelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1781" to="1785" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies</title>
		<author>
			<persName><forename type="first">C</forename><surname>Colombo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Minna</forename><forename type="middle">E</forename><surname>Rizzetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Romeo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lecis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Persani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mondellini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pierotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Greco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fugazzola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Borrello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Orphanet J Rare Dis</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">25</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Couce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bautista</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Carter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagn Mol Pathol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="71" to="79" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">RET mutation and expression in small-cell lung cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Dabir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Babakoohi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kluge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Morrow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kresak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Macpherson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wildey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dowlati</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Thorac Oncol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1316" to="1323" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Allelic dilution obscures detection of a biologically significant resistance mutation in EGFRamplified lung cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Engelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mukohara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Zejnullahu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lifshits</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Borras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Gale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Naumov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Y</forename><surname>Yeap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Jarrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tracy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Heymach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Cantley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Janne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2695" to="2706" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Afatinib: a first-line treatment for selected patients with metastatic non-small-cell lung cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Engle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Kolesar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Health Syst Pharm</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="1933" to="1938" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Esteller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sanchez-Cespedes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rosell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sidransky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Baylin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Herman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="67" to="70" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Frequent mutations in chromatinremodelling genes in pulmonary carcinoids</title>
		<author>
			<persName><forename type="first">L</forename><surname>Fernandez-Cuesta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peifer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ozretic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Seidel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Leenders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dahmen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pinther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bosco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Konrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Altmuller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nurnberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Achter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bogus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Soltermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">T</forename><surname>Brustugun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Helland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Solberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lund-Iversen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Stoelben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wainer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Field</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hyde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Heukamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Perner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Lovly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cappuzzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Travis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vingron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Brambilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Haas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Buettner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Thomas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">3518</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature</title>
		<author>
			<persName><forename type="first">G</forename><surname>Fink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Krelbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yellin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bendayan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saute</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Glazer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Kramer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1647" to="1651" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Allelic loss of DNA locus of the RET proto-oncogene in small cell lung cancer</title>
		<author>
			<persName><forename type="first">H</forename><surname>Futami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Egawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tsukada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shiraishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yamaguchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="59" to="65" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung</title>
		<author>
			<persName><forename type="first">M</forename><surname>Garcia-Yuste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Matilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cueto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Paniagua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ramos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Canizares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Muguruza</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cardiothorac Surg</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="192" to="197" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Glubb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cerri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Giese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Mirza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Das</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jassem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Rzyman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Lingen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Salgia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Hirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dziadziuszko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ballmer-Hofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Innocenti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="5257" to="5267" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond</title>
		<author>
			<persName><forename type="first">N</forename><surname>Karachaliou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rosell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Biol Med</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="173" to="181" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Krampitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Norton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1920" to="1931" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Henikoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Ng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Protoc</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1073" to="1081" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Genetics of neuroendocrine and carcinoid tumours</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Leotlela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Holtgreve-Grez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Thakker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Relat Cancer</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="437" to="450" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Infrequent mutations of the p53 gene in pulmonary carcinoid tumors</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Lohmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fesseler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Putz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Reich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bohm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Prauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Wunsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hofler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="5797" to="5801" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mclaren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pritchard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rios</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Flicek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cunningham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="2069" to="2070" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Peifer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fernandez-Cuesta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Sos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Seidel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Kasper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Plenker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Leenders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Menon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dahmen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Cerbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Schildhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Altmuller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Baessmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>De Wilde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vandesompele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bohm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gabler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wilkening</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Heynck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heuckmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Cibulskis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Banerji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Getz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Rauh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Grutter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pasqualucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wainer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Stoelben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schnabel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Muley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Brockmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Engel-Riedel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Muscarella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Fazio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Groen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Timens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Sietsma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thunnissen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Smit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Heideman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Snijders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Cappuzzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ligorio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Damiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Field</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Solberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brustugun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">T</forename><surname>Lund-Iversen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sanger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Clement</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Soltermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Weder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Soria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Validire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Besse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Brambilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Brambilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lantuejoul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lorimier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Hallek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Meyerson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shendure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Buttner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nurnberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Perner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heukamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Brindle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Haas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1104" to="1110" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Alteration of the E-cadherin/betacatenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids</title>
		<author>
			<persName><forename type="first">G</forename><surname>Pelosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scarpa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Puppa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Veronesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Spaggiari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pasini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Maisonneuve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iannucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Arrigoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Viale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1154" to="1164" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Efficacy analysis of tyrosine kinase inhibitors on rare non-small cell lung cancer patients harboring complex EGFR mutations</title>
		<author>
			<persName><forename type="first">L</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">G</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Jiao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">6104</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Pettitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Sherrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Cawley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Stankovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="814" to="822" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Przygodzki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Finkelstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Langer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Swalsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fishback</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bakker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Guinee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Travis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1531" to="1541" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Outcome and surgical strategy in bronchial carcinoid tumours: single institution experience with 252 patients</title>
		<author>
			<persName><forename type="first">F</forename><surname>Rea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rizzardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zuin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Marulli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nicotra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bulf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schiavon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sartori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cardiothorac Surg</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="186" to="191" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Neuroendocrine tumors of the lung: an update</title>
		<author>
			<persName><forename type="first">N</forename><surname>Rekhtman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Pathol Lab Med</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1628" to="1638" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Predicting the functional impact of protein mutations: application to cancer genomics</title>
		<author>
			<persName><forename type="first">B</forename><surname>Reva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Antipin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sander</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page">e118</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification</title>
		<author>
			<persName><forename type="first">S</forename><surname>Revannasiddaiah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Thakur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bhardwaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Susheela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Madabhavi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Thorac Dis</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="S502" to="S525" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction</title>
		<author>
			<persName><forename type="first">G</forename><surname>Rindi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Petrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Inzani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Pathol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="186" to="192" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rotondi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ercolino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fonte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Lagonigro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Leporati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Villani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">La</forename><surname>Manna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mannelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chiovato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol Invest</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="115" to="118" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Schulte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Machens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fugazzola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mcgregor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Diaz-Cano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Izatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Aylwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Talat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Beck-Peccoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Dralle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="E92" to="E97" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Surgical treatment of other bronchial tumors</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Scott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chest Surg Clin N Am</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="111" to="128" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Sequist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Waltman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dias-Santagata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Digumarthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Turke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fidias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bergethon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gettinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Cosper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Akhavanfard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Heist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Temel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Wain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Lynch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Vernovsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Mark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lanuti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Iafrate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mino-Kenudson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Engelman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Transl Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">75</biblScope>
			<biblScope unit="page" from="75" to="101" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Oncogene mimicry as a mechanism of primary resistance to BRAF inhibitors</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Sos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Gordan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Oses-Prieto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Webber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Salt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Burlingame</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mccormick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bandyopadhyay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Shokat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1037" to="1048" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">CD44 and OTP are strong prognostic markers for pulmonary carcinoids</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Swarts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Henfling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Van Neste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Van Suylen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Dingemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">N</forename><surname>Dinjens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haesevoets</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rudelius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Thunnissen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Volante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Van Criekinge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Engeland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Ramaekers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Speel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2197" to="2207" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Swarts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Ramaekers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Speel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1826</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="255" to="271" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases</title>
		<author>
			<persName><forename type="first">H</forename><surname>Takei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Asamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maeshima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Niki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tsuchiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Matsuno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Thorac Cardiovasc Surg</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="285" to="292" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement</title>
		<author>
			<persName><forename type="first">Thomas</forename><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Tazelaar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Jett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1143" to="1150" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Lung tumours with neuroendocrine differentiation</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Travis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="251" to="266" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Travis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Rush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Flieder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Falk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Gal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Koss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="934" to="944" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">World Health Organization, International Agency for Research on Cancer, International Association for the Study of Lung Cancer</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Travis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pathology and Genetics of Tumours of the Lung</title>
		<imprint>
			<date type="published" when="2004">2004</date>
			<publisher>Lyon</publisher>
		</imprint>
	</monogr>
	<note>International Academy of Pathology</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Polymorphisms of KDR gene are associated with coronary heart disease</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Qin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="760" to="767" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">RET proto oncogene mutation detection and medullary thyroid carcinoma prevention</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Z</forename><surname>Yeganeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sheikholeslami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hedayati</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Asian Pac J Cancer Prev</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2107" to="2117" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Aberrant promoter methylation of multiple genes in non-small cell lung cancers</title>
		<author>
			<persName><forename type="first">S</forename><surname>Zochbauer-Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Fong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Virmani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Geradts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Gazdar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Minna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="249" to="255" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
